Newcore Gold Ltd. (PCR.V) (CVE:PCR – Get Free Report) Director Barry Johnson Blayne acquired 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 24th. The stock was acquired at an average cost of C$0.31 per share, with a total value of C$15,250.00.
Newcore Gold Ltd. (PCR.V) Stock Performance
CVE:PCR opened at C$0.74 on Wednesday. The stock has a market cap of C$59.16 million and a price-to-earnings ratio of -185.00. Newcore Gold Ltd. has a 1 year low of C$0.14 and a 1 year high of C$0.86. The business has a fifty day moving average of C$0.74 and a 200-day moving average of C$0.74.
About Newcore Gold Ltd. (PCR.V)
Featured Stories
- Five stocks we like better than Newcore Gold Ltd. (PCR.V)
- What is the S&P/TSX Index?
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- What Are Some of the Best Large-Cap Stocks to Buy?
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- The Role Economic Reports Play in a Successful Investment Strategy
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Newcore Gold Ltd. (PCR.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newcore Gold Ltd. (PCR.V) and related companies with MarketBeat.com's FREE daily email newsletter.